FABP4 and hepatocellular carcinoma: Next, we investigated the therapeutic potential of the anti-FABP4 mAb in suppressing tumor growth in a MASLD-HCC mouse model induced by orthotopic injection of RIL-175 mouse HCC cells into the liver of mice fed a HFD for 13 weeks (Figure 7H).